JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuehler, A
Right arrow Articles by Ceballos-Baumann, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuehler, A
Right arrow Articles by Ceballos-Baumann, A
Journal of Neurology Neurosurgery and Psychiatry 2003;74:1023-1030
© 2003 BMJ Publishing Group


PAPER

A novel quality of life instrument for deep brain stimulation in movement disorders

A Kuehler1, G Henrich2, U Schroeder1, B Conrad1, P Herschbach2, A Ceballos-Baumann1

1 Department of Neurology, Technische Universität München, Munich, Germany
2 Department of Psychosomatic Medicine, Technische Universität München

Correspondence to:
Correspondence to:
Prof Dr A Ceballos-Baumann, Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Möhlstrasse 28, D-81675 Munich, Germany;
a.ceballos{at}lrz.tum.de

Objective: To develop a short instrument to examine quality of life (QoL) which specifically addresses patients with movement disorders treated by deep brain stimulation (DBS).

Design: The instrument was developed within an existing concept of a modular questionnaire (questions on life satisfaction: "general life satisfaction" QLSM-A, and "satisfaction with health" QLSM-G), in which each item is weighted according to its relative importance to the individual.

Methods: Items were generated by interviews with 20 DBS patients, followed by item reduction and scale generation, factor analysis to determine relevant and final questionnaire items, estimation of reliability, and validation based on the medical outcome study 36 item short form health survey (SF-36) and the EuroQol (EQ-5D) (data from 152 patients with Parkinson’s disease, essential tremor, or idiopathic torsion dystonia, including 75 patients with DBS).

Results: Initial questionnaires were reduced to 12 items for a "movement disorder module" (QLSM-MD), and five items for a "deep brain stimulation module" (QLSM-DBS). Psychometric analysis revealed Cronbach’s {alpha} values of of 0.87 and 0.73, and satisfactory correlation coefficients for convergent validity with SF-36 and EQ-5D.

Conclusions: QLSM-MD and QLSM-DBS can evaluate quality of life aspects of DBS in movement disorders. Psychometric evaluation showed the questionnaires to be reliable, valid, and well accepted by the patients.


Keywords: quality of life instrument; movement disorders; deep brain stimulation

Abbreviations: DBS, deep brain stimulation; EQ-5D, EuroQol survey; PCA, principal component analysis; QLSM, questions on life satisfactionmodules; QLSM-A, questions on life satisfaction, general satisfaction; QLSM-G, questions on life satisfaction, satisfaction with health; QLSM-DBS, questions on life satisfaction, deep brain stimulation; QLSM-MD, questions on life satisfaction, movement disorder; QoL, quality of life; SF-36, medical outcome study 36 item short form health survey




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Diamond and J Jankovic
The effect of deep brain stimulation on quality of life in movement disorders
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1188 - 1193.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M C Rodriguez-Oroz, I Zamarbide, J Guridi, M R Palmero, and J A Obeso
Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation
J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1382 - 1385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.